Bausch Health Companies Inc (MEX:BHC) Stock News, Headlines & Updates
Bausch Health Companies Inc Stock News from GuruFocus
- 1
Jun 21, 2024
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
ACCESSWIRE • 7:00pm
Jun 14, 2024
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
ACCESSWIRE • 3:00pm
May 23, 2024
Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults
ACCESSWIRE • 11:00am
May 17, 2024
Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
ACCESSWIRE • 11:00am
May 15, 2024
Bausch Health Announces 2024 Annual Meeting of Shareholder Results
ACCESSWIRE • 11:00am
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
ACCESSWIRE • 7:00pm
May 09, 2024
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
ACCESSWIRE • 11:00am
May 03, 2024
Q1 2024 Bausch Health Companies Inc Earnings Call Transcript
GuruFocus Research • 11:13pm
May 02, 2024
Bausch Health Companies Inc Reports Q1 2024 Earnings: A Detailed Analysis Compared to Analyst Estimates
GuruFocus Research • 6:38am
Apr 12, 2024
Bausch Health to Announce First-Quarter 2024 Results on May 2
ACCESSWIRE • 7:00pm
Apr 11, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news